标题
Epigenetic modulators as therapeutic targets in prostate cancer
作者
关键词
Prostate cancer, DNMTi, Histone modulators
出版物
Clinical Epigenetics
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-09-15
DOI
10.1186/s13148-016-0264-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A phase I/II randomized study of panobinostat and bicalutamide in castration-resistant prostate cancer (CRPC) patients progressing on second-line hormone therapy.
- (2017) A. C. Ferrari et al. JOURNAL OF CLINICAL ONCOLOGY
- Bromodomains: Structure, function and pharmacology of inhibition
- (2016) Elena Ferri et al. BIOCHEMICAL PHARMACOLOGY
- Targeting cancer using KAT inhibitors to mimic lethal knockouts
- (2016) J. A. L. Brown et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Modulation of p300/CBP Acetylation of Nucleosomes by Bromodomain Ligand I-CBP112
- (2016) Beth E. Zucconi et al. BIOCHEMISTRY
- DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers
- (2016) Ching-Yu Yen et al. CANCER LETTERS
- Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response
- (2016) Andrew R. Conery et al. CANCER RESEARCH
- Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapy
- (2016) Ryuji Hamamoto et al. CANCER SCIENCE
- Inside HDACs with more selective HDAC inhibitors
- (2016) Joëlle Roche et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Sulforaphane increases the efficacy of anti-androgens by rapidly decreasing androgen receptor levels in prostate cancer cells
- (2016) Namrata Khurana et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Sulforaphane Inhibits c-Myc-Mediated Prostate Cancer Stem-Like Traits
- (2016) Avani R. Vyas et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells
- (2016) Shundong Cang et al. Journal of Hematology & Oncology
- KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases
- (2016) Roman P. Simon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer
- (2016) I. A. Asangani et al. MOLECULAR CANCER RESEARCH
- Phenethyl isothiocyanate (PEITC) suppresses prostate cancer cell invasion epigenetically through regulating microRNA-194
- (2016) Chengyue Zhang et al. MOLECULAR NUTRITION & FOOD RESEARCH
- The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study
- (2016) Hakim Mahammedi et al. ONCOLOGY
- Embelin inhibits proliferation, induces apoptosis and alters gene expression profiles in breast cancer cells
- (2016) Priyank Shah et al. Pharmacological Reports
- Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells
- (2016) Reshma R.S. et al. PHARMACOLOGICAL RESEARCH
- CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy
- (2016) Huiying Sun et al. Hormones & Cancer
- Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo
- (2015) Min Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Garcinol: Current status of its anti-oxidative, anti-inflammatory and anti-cancer effects
- (2015) Chaoqun Liu et al. CANCER LETTERS
- Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy
- (2015) B. G. Cipolla et al. Cancer Prevention Research
- Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
- (2015) S. Picaud et al. CANCER RESEARCH
- The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
- (2015) M. Boi et al. CLINICAL CANCER RESEARCH
- Phase I/II Study of Azacitidine, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy
- (2015) Rakesh Singal et al. Clinical Genitourinary Cancer
- Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts
- (2015) Pragya Srivastava et al. Epigenetics
- Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells
- (2015) Erika M. Weaver et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)
- (2015) Nicholas David James et al. EUROPEAN UROLOGY
- Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma
- (2015) Paul G Richardson et al. Expert Review of Anticancer Therapy
- Valproic acid inhibits the invasion of PC3 prostate cancer cells by upregulating the metastasis suppressor protein NDRG1
- (2015) Jae Eun Lee et al. GENETICS AND MOLECULAR BIOLOGY
- Epigenetic-based therapy: From single- to multi-target approaches
- (2015) Rosaria Benedetti et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195
- (2015) B. J. Eigl et al. INVESTIGATIONAL NEW DRUGS
- Antitumor Activity of Garcinol in Human Prostate Cancer Cells and Xenograft Mice
- (2015) Yu Wang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Valproic acid (VPA) inhibits the epithelial–mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4
- (2015) Xiaopeng Lan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation
- (2015) Abeer M. Mahmoud et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
- (2015) Jean-Pierre J Issa et al. LANCET ONCOLOGY
- Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re-expressing the epigenetically repressed tumor suppressor-estrogen receptor β
- (2015) Vikas Sharma et al. MOLECULAR CARCINOGENESIS
- The evolutionary history of lethal metastatic prostate cancer
- (2015) Gunes Gundem et al. NATURE
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models
- (2015) P L Garcia et al. ONCOGENE
- Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling
- (2015) Nahee Park et al. PLoS One
- Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells
- (2015) Shu-Feng Zhou et al. Drug Design Development and Therapy
- SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3
- (2015) Filipa Quintela Vieira et al. Oncotarget
- Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes
- (2015) Jessamy C. Tiffen et al. Oncotarget
- Hydrazinobenzoylcurcumin inhibits androgen receptor activity and growth of castration-resistant prostate cancer in mice
- (2015) Min Wu et al. Oncotarget
- BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
- (2015) Marie-Magdelaine Coudé et al. Oncotarget
- Epigenetic treatment of solid tumours: a review of clinical trials
- (2015) Clara Nervi et al. Clinical Epigenetics
- DNA Methyltransferase Inhibitor Zebularine Induces Human Cholangiocarcinoma Cell Death through Alteration of DNA Methylation Status
- (2015) Kazuaki Nakamura et al. PLoS One
- Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer
- (2015) Tiago Baptista et al. Oncotarget
- Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.
- (2015) Anastasia Wyce et al. Oncotarget
- Anti-neoplastic properties of hydralazine in prostate cancer
- (2015) Inês Graça et al. Oncotarget
- A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I
- (2014) Chia-Chun Yu et al. BIOCHEMICAL PHARMACOLOGY
- Synthesis and activity of tumor-homing peptide iRGD and histone deacetylase inhibitor valproic acid conjugate
- (2014) Zheng-Hong Peng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers
- (2014) Jennifer J. Wheler et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy
- (2014) Hideyuki Takeshima et al. CARCINOGENESIS
- Embelin Sensitizes Acute Myeloid Leukemia Cells to TRAIL through XIAP Inhibition and NF-κB Inactivation
- (2014) Tianxin Yang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Anti-Tumoral Effect of the Non-Nucleoside DNMT Inhibitor RG108 in Human Prostate Cancer Cells
- (2014) Ines Graca et al. CURRENT PHARMACEUTICAL DESIGN
- Belinostat: First Global Approval
- (2014) Raewyn M. Poole DRUGS
- A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer
- (2014) Joshi J. Alumkal et al. INVESTIGATIONAL NEW DRUGS
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting DNA Methylation with Small Molecules: What’s Next?
- (2014) Alexandre Erdmann et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Inhibitors of Protein Methyltransferases
- (2014) H. Ümit Kaniskan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Non-nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including in Cancer Stem Cells
- (2014) Sergio Valente et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synergistic Loss of Prostate Cancer Cell Viability by Coinhibition of HDAC and PARP
- (2014) O. S. Chao et al. MOLECULAR CANCER RESEARCH
- Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
- (2014) S. K. Knutson et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
- (2014) Irfan A. Asangani et al. NATURE
- Emerging mechanisms of enzalutamide resistance in prostate cancer
- (2014) Frank Claessens et al. Nature Reviews Urology
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers
- (2014) Julie Bauman et al. Translational Oncology
- Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a
- (2014) Ramzi F. Sweis et al. ACS Medicinal Chemistry Letters
- Impact of Soy Isoflavones on the Epigenome in Cancer Prevention
- (2014) Maria Pudenz et al. Nutrients
- Rational design and validation of a Tip60 histone acetyltransferase inhibitor
- (2014) Chunxia Gao et al. Scientific Reports
- Selectively Targeting Prostate Cancer with Antiandrogen Equipped Histone Deacetylase Inhibitors
- (2013) Berkley E. Gryder et al. ACS Chemical Biology
- Identification of Novel Inhibitors of DNA Methylation by Screening of a Chemical Library
- (2013) Alexandre Ceccaldi et al. ACS Chemical Biology
- Probing p300/CBP Associated Factor (PCAF)-Dependent Pathways with a Small Molecule Inhibitor
- (2013) Rahul Modak et al. ACS Chemical Biology
- DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells
- (2013) Ju-Kyung Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The discovery and optimization of novel dual inhibitors of topoisomerase ii and histone deacetylase
- (2013) Xuan Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis, and biological evaluation of novel histone deacetylase 1 inhibitors through click chemistry
- (2013) Qiao Sun et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762
- (2013) A. Chaidos et al. BLOOD
- A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
- (2013) Dana E. Rathkopf et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Valproic acid inhibits the proliferation of cancer cells by re-expressing cyclin D2
- (2013) Daria Witt et al. CARCINOGENESIS
- Anacardic acid (6-pentadecylsalicylic acid) induces apoptosis of prostate cancer cells through inhibition of androgen receptor and activation of p53 signaling
- (2013) Jing Tan et al. Chinese Journal of Cancer Research
- Deregulated expression of selected histone methylases and demethylases in prostate carcinoma
- (2013) Filipa Quintela Vieira et al. ENDOCRINE-RELATED CANCER
- Zebularine partially reverses GST methylation in prostate cancer cells and restores sensitivity to the DNA minor groove binder brostallicin
- (2013) Maria Antonietta Sabatino et al. Epigenetics
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- 3-Hydroxypyridin-2-thione as Novel Zinc Binding Group for Selective Histone Deacetylase Inhibition
- (2013) Vishal Patil et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine-Specific Demethylases Display High Anticancer Activities
- (2013) Dante Rotili et al. JOURNAL OF MEDICINAL CHEMISTRY
- New Benzothiazole/thiazole-Containing Hydroxamic Acids as Potent Histone Deacetylase Inhibitors and Antitumor Agents
- (2013) Truong Tung et al. Medicinal Chemistry
- Zebularine inhibits the growth of A549 lung cancer cells via cell cycle arrest and apoptosis
- (2013) Bo Ra You et al. MOLECULAR CARCINOGENESIS
- The future of epigenetic therapy in solid tumours—lessons from the past
- (2013) Nilofer Azad et al. Nature Reviews Clinical Oncology
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Androgen receptors in hormone-dependent and castration-resistant prostate cancer
- (2013) Ayesha A. Shafi et al. PHARMACOLOGY & THERAPEUTICS
- Sodium Butyrate Induces Growth Inhibition and Apoptosis in Human Prostate Cancer DU145 Cells by Up-Regulation of the Expression of Annexin A1
- (2013) Dawei Mu et al. PLoS One
- Combination Therapy with the Histone Deacetylase Inhibitor LBH589 and Radiation Is an Effective Regimen for Prostate Cancer Cells
- (2013) Weiwei Xiao et al. PLoS One
- Development of a histone deacetylase 6 inhibitor and its biological effects
- (2013) J.-H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer
- (2013) Teruyuki Sato et al. Scientific Reports
- Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2
- (2012) Peter H. Killian et al. CARCINOGENESIS
- DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E-cadherin re-expression by chromatin remodelling
- (2012) Jurate Savickiene et al. CELL BIOLOGY INTERNATIONAL
- Castration-resistant prostate cancer: systemic therapy in 2012
- (2012) FC Maluf et al. Clinics
- Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor
- (2012) Dominica Willmann et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting the Unique Methylation Pattern of Androgen Receptor (AR) Promoter in Prostate Stem/Progenitor Cells with 5-Aza-2′-deoxycytidine (5-AZA) Leads to Suppressed Prostate Tumorigenesis
- (2012) Jing Tian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery and Characterization of NK13650s, Naturally Occurring p300-Selective Histone Acetyltransferase Inhibitors
- (2012) Shigehiro Tohyama et al. JOURNAL OF ORGANIC CHEMISTRY
- Histone deacetylases and cancer
- (2012) Bruna Barneda-Zahonero et al. Molecular Oncology
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- The complexity of prostate cancer: genomic alterations and heterogeneity
- (2012) Lara K. Boyd et al. Nature Reviews Urology
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination Therapy of Antiandrogen and XIAP Inhibitor for Treating Advanced Prostate Cancer
- (2012) Michael Danquah et al. PHARMACEUTICAL RESEARCH
- Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer
- (2012) Kelly Coffey et al. PLoS One
- Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades
- (2012) Seong Won Kim et al. PROSTATE
- EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
- (2012) K. Xu et al. SCIENCE
- Epigenetic CpG Demethylation of the Promoter and Reactivation of the Expression of Neurog1 by Curcumin in Prostate LNCaP Cells
- (2011) Limin Shu et al. AAPS Journal
- Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors
- (2011) Hanae Benelkebir et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2
- (2011) Li Lai et al. BRITISH JOURNAL OF PHARMACOLOGY
- Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells
- (2011) Yu-Wei Chou et al. CANCER LETTERS
- Rapid Synthesis of New DNMT Inhibitors Derivatives of Procainamide
- (2011) Ludovic Halby et al. CHEMBIOCHEM
- Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
- (2011) Carmen Jerónimo et al. EUROPEAN UROLOGY
- Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
- (2011) Karen M VanderMolen et al. JOURNAL OF ANTIBIOTICS
- Novel 3,5-Bis(bromohydroxybenzylidene)piperidin-4-ones as Coactivator-Associated Arginine Methyltransferase 1 Inhibitors: Enzyme Selectivity and Cellular Activity
- (2011) Donghang Cheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lysine Demethylases Inhibitors
- (2011) Takayoshi Suzuki et al. JOURNAL OF MEDICINAL CHEMISTRY
- Total Syntheses of the Histone Deacetylase Inhibitors Largazole and 2-epi-Largazole: Application ofN-Heterocyclic Carbene Mediated Acylations in Complex Molecule Synthesis
- (2011) Bo Wang et al. JOURNAL OF ORGANIC CHEMISTRY
- Chemopreventative Potential of the Cruciferous Vegetable Constituent Phenethyl Isothiocyanate in a Mouse Model of Prostate Cancer
- (2011) Anna A. Powolny et al. JNCI-Journal of the National Cancer Institute
- Novel Folate-Hydroxamate Based Antimetabolites: Synthesis and Biological Evaluation
- (2011) Marta P. Carrasco et al. Medicinal Chemistry
- Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer
- (2011) Francesco Crea et al. Molecular Cancer
- Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines
- (2011) F. R. Santer et al. MOLECULAR CANCER THERAPEUTICS
- Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor
- (2011) Y. Kong et al. MOLECULAR CANCER THERAPEUTICS
- Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
- (2011) A. Nebbioso et al. MOLECULAR CANCER THERAPEUTICS
- Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells
- (2011) John D. Clarke et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Cancer epigenetics reaches mainstream oncology
- (2011) Manuel Rodríguez-Paredes et al. NATURE MEDICINE
- Histone onco-modifications
- (2011) J Füllgrabe et al. ONCOGENE
- Epigenetic cancer therapy: rationales, targets and drugs
- (2011) M Rius et al. ONCOGENE
- Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo
- (2011) Kozue Sakao et al. PROSTATE
- Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells
- (2011) Praveen Rajendran et al. Clinical Epigenetics
- S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition
- (2010) Annette Hayden et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer
- (2010) Dana Rathkopf et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
- (2010) T. Bianco-Miotto et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Structure and Function of Mammalian DNA Methyltransferases
- (2010) Renata Zofia Jurkowska et al. CHEMBIOCHEM
- Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
- (2010) Erin M. Bowers et al. CHEMISTRY & BIOLOGY
- Nitric Oxide-Mediated Histone Hyperacetylation in Oral Cancer: Target for a Water-Soluble HAT Inhibitor, CTK7A
- (2010) Mohammed Arif et al. CHEMISTRY & BIOLOGY
- Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene
- (2010) Hagit Schayek et al. EXPERIMENTAL CELL RESEARCH
- Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells
- (2010) Piergiorgio Pettazzoni et al. FREE RADICAL BIOLOGY AND MEDICINE
- Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies
- (2010) Bryan J. Schneider et al. INVESTIGATIONAL NEW DRUGS
- Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer
- (2010) Xiong Cai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results
- (2010) Jaime Coronel et al. MEDICAL ONCOLOGY
- SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer
- (2010) V. Novotny-Diermayr et al. MOLECULAR CANCER THERAPEUTICS
- Delivery of 5-Azacytidine to Human Cancer Cells by Elaidic Acid Esterification Increases Therapeutic Drug Efficacy
- (2010) B. Brueckner et al. MOLECULAR CANCER THERAPEUTICS
- Nanaomycin A Selectively Inhibits DNMT3B and Reactivates Silenced Tumor Suppressor Genes in Human Cancer Cells
- (2010) D. Kuck et al. MOLECULAR CANCER THERAPEUTICS
- S110, a 5-Aza-2'-Deoxycytidine-Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth
- (2010) J. C. Chuang et al. MOLECULAR CANCER THERAPEUTICS
- Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases
- (2010) P.-H. Huang et al. MOLECULAR PHARMACOLOGY
- The epigenome as a therapeutic target in prostate cancer
- (2010) Antoinette S. Perry et al. Nature Reviews Urology
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of the androgen receptor by SET9-mediated methylation
- (2010) Luke Gaughan et al. NUCLEIC ACIDS RESEARCH
- 5-azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors
- (2010) Giovanni Luca Gravina et al. PROSTATE
- Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth
- (2010) Jianqing Lin et al. PROSTATE
- Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
- (2009) L. R. Molife et al. ANNALS OF ONCOLOGY
- Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
- (2009) P N Munster et al. BRITISH JOURNAL OF CANCER
- Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)
- (2009) Deborah Bradley et al. CANCER
- A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its Degradation
- (2009) J. Datta et al. CANCER RESEARCH
- Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors
- (2009) R. Plummer et al. CLINICAL CANCER RESEARCH
- High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
- (2009) K. Iljin et al. CLINICAL CANCER RESEARCH
- Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models
- (2009) Claudio Festuccia et al. ENDOCRINE-RELATED CANCER
- Inhibition of Lysine Acetyltransferase KAT3B/p300 Activity by a Naturally Occurring Hydroxynaphthoquinone, Plumbagin
- (2009) Kodihalli C. Ravindra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone deacetylase inhibitors: Potential in cancer therapy
- (2009) P.A. Marks et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- New Developments in the Medical Management of Prostate Cancer
- (2009) Manish Kohli et al. MAYO CLINIC PROCEEDINGS
- DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
- (2009) T. B. Miranda et al. MOLECULAR CANCER THERAPEUTICS
- Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6
- (2009) A. Gibbs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global levels of histone modifications predict prostate cancer recurrence
- (2009) Jörg Ellinger et al. PROSTATE
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer
- (2009) Guru Sonpavde et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression
- (2008) Yinhong Song et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- DNA Hypomethylation Arises Later in Prostate Cancer Progression than CpG Island Hypermethylation and Contributes to Metastatic Tumor Heterogeneity
- (2008) Srinivasan Yegnasubramanian et al. CANCER RESEARCH
- A Phase I Biological Study of MG98, an Oligodeoxynucleotide Antisense to DNA Methyltransferase 1, in Patients with High-Risk Myelodysplasia and Acute Myeloid Leukemia
- (2008) R. B. Klisovic et al. CLINICAL CANCER RESEARCH
- Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study
- (2008) Dominik R. Berthold et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells
- (2008) Giovanni Luca Gravina et al. PROSTATE
- Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25Å
- (2007) Shinya Mimasu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Depsipeptide (FK228) inhibits growth of human prostate cancer cells
- (2007) Ming-Tsung Lai et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now